zum Inhalt springen

Fachbereich Veterinärmedizin


Service-Navigation

    Publikationsdatenbank

    The circadian dynamics of the hippocampal transcriptome and proteome is altered in experimental temporal lobe epilepsy (2020)

    Art
    Zeitschriftenartikel / wissenschaftlicher Beitrag
    Autoren
    Debski, K. J.
    Ceglia, N.
    Ghestem, A.
    Ivanov, A. I.
    Brancati, G. E.
    Bröer, S.
    Bot, A. M.
    Müller, J. A.
    Schoch, S.
    Becker, A.
    Löscher, W.
    Guye, M.
    Sassone-Corsi, P.
    Lukasiuk, K.
    Baldi, P.
    Bernard, C.
    Quelle
    Science advances
    Bandzählung: 6
    Heftzählung: 41
    Seiten: eaat5979
    ISSN: 2375-2548
    Sprache
    Englisch
    Verweise
    URL (Volltext): https://advances.sciencemag.org/content/6/41/eaat5979
    DOI: 10.1126/sciadv.aat5979
    Pubmed: 33036982
    Kontakt
    Institut für Pharmakologie und Toxikologie

    Koserstr. 20
    14195 Berlin
    +49 30 838 53221
    pharmakologie@vetmed.fu-berlin.de

    Abstract / Zusammenfassung

    Gene and protein expressions display circadian oscillations, which can be disrupted in diseases in most body organs. Whether these oscillations occur in the healthy hippocampus and whether they are altered in epilepsy are not known. We identified more than 1200 daily oscillating transcripts in the hippocampus of control mice and 1600 in experimental epilepsy, with only one-fourth oscillating in both conditions. Comparison of gene oscillations in control and epilepsy predicted time-dependent alterations in energy metabolism, which were verified experimentally. Although aerobic glycolysis remained constant from morning to afternoon in controls, it increased in epilepsy. In contrast, oxidative phosphorylation increased in control and decreased in epilepsy. Thus, the control hippocampus shows circadian molecular remapping, which is altered in epilepsy. We suggest that the hippocampus operates in a different functioning mode in epilepsy. These alterations need to be considered when studying epilepsy mechanisms, designing drug treatments, and timing their delivery.